transdermal_patches
Table of Contents
transdermal patches
introduction
- transdermal patches can be an effective drug delivery route
- they deliver medication at a constant rate via the skin into the bloodstream for a prolonged effect.
- increasing numbers of medications are becoming available in transdermal patch form.
- however they may also be associated with serious adverse events.
- Australian and international reports show high incident rates particularly with opioid (fentanyl, buprenorphine resulting in opioid respiratory depression) and glyceryl trinitrate patches (resulting in postural hypotension).
- appropriate prescribing, correct application and removal, careful education and monitoring of patients and correct disposal can reduce the risk of adverse events.
prescribing in hospitals
- prescriptions on drug charts should include:
- drug generic name +/- trade name
- patch dose
- hourly dose for fentanyl
- % concentration for lignocaine
- most other patches: 24 hour dose
- frequency of application
- fentanyl is usually every 3 days
- buprenorphine is applied every week
- for patches > 24hrs, prescriber MUST write the nursing ‘Check Application’ section
- drug-free periods
- if the patch has specific ON and OFF times (e.g. glyceryl trinitrate patches), clearly specify this on the “Administration times” section of the medication chart.
- eg. if use patch overnight only, indicate OFF 0800 and ON 2000
- timing of application
- a midday changeover for opioid patches is preferred as this allows decisions to be made on the morning round prior to any re-application.
application of patch
- BEFORE applying new patch:
- check to ensure old patch has been removed
- discard patch into the sharps container/infectious waste bin by folding adhesive sides together.
- discarding of opioid patches is to be witnessed by two RN/RM/ENmed/MO one of whom must be an RN or RM.
- an entry is to be made in the comments section of the Controlled Drug (CD) administration book, including the method of destruction.
- do not cut a patch to adjust a dose
- application:
- avoid exposure to the drug by wearing protective gloves during application, removal and disposal. Without touching the adhesive, remove the plastic backing.
- apply the patch evenly to clean, dry, hairless skin on the upper body, ideally a site that is easily accessed by staff to check application.
- rotate the site with each application to minimise risk of skin reactions.
- document application on the:
- medication chart (document the time and date).
- Functional Maintenance Care Plan
- patch itself (document the time AND date of application).
- note whether the patch requires a drug-free period e.g. glyceryl trinitrate and some nicotine patches.
- communicate patch information on handover.
- for patches that remain in situ for more than 24 hours (Figure 3), to prevent inadvertent removal of patch or doubling up of patches, every patch must be checked once a shift: AM (Morning Shift), PM (Afternoon Shift) and Night (Night Shift).
- this is to be documented by:
- if the patch is correctly in place tick the appropriate box of the ‘Check Application’ section located in the administration section of the order.
- if patch falls off (either partly or entirely), write ‘OFF’ in the ‘Check Application’ section. Do not re-apply the same patch. Inform the treating team or pharmacist and apply a new patch if deemed appropriate and ensure that the prescription is altered on the drug chart if necessary.
- other considerations:
- Fentanyl patch dosing may require the application of more than one patch eg 37 microg/hour requires two patches (25 microg/hour and 12 microg/hour patch).
- do not apply patches to broken, infected or cut skin. If patient has body hair where a patch is to be applied, the hair must be cut short and not shaved.
- do not apply the patch immediately after a hot shower. Wait until the skin is cool and dry.
- do not apply heat (including heat pack, electric blanket, hot water bottle, sauna, and spa) on or near the patch, as it may result in an increased rate of drug absorption.
transdermal_patches.txt · Last modified: 2013/11/15 01:34 by 127.0.0.1